1138 related articles for article (PubMed ID: 23643470)
1. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
Iglesias-García O; Pelacho B; Prósper F
J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
[TBL] [Abstract][Full Text] [Related]
2. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
3. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro.
Kuzmenkin A; Liang H; Xu G; Pfannkuche K; Eichhorn H; Fatima A; Luo H; Saric T; Wernig M; Jaenisch R; Hescheler J
FASEB J; 2009 Dec; 23(12):4168-80. PubMed ID: 19703934
[TBL] [Abstract][Full Text] [Related]
5. Induced Pluripotent Stem Cells as a new Strategy for Osteogenesis and Bone Regeneration.
Lou X
Stem Cell Rev Rep; 2015 Aug; 11(4):645-51. PubMed ID: 26022504
[TBL] [Abstract][Full Text] [Related]
6. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
7. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era.
Yuasa S; Fukuda K
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):803-10. PubMed ID: 18570618
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes.
Jiang B; Dong H; Li Q; Yu Y; Zhang Z; Zhang Y; Wang G; Zhang Z
Cell Biochem Biophys; 2013 Jun; 66(2):309-18. PubMed ID: 23212180
[TBL] [Abstract][Full Text] [Related]
10. Strategies for replacing myocytes with induced pluripotent stem in clinical protocols.
Hattori F; Fukuda K
Transplant Rev (Orlando); 2012 Jul; 26(3):223-32. PubMed ID: 22172453
[TBL] [Abstract][Full Text] [Related]
11. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
Narazaki G; Uosaki H; Teranishi M; Okita K; Kim B; Matsuoka S; Yamanaka S; Yamashita JK
Circulation; 2008 Jul; 118(5):498-506. PubMed ID: 18625891
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
[TBL] [Abstract][Full Text] [Related]
13. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.
Xi J; Khalil M; Shishechian N; Hannes T; Pfannkuche K; Liang H; Fatima A; Haustein M; Suhr F; Bloch W; Reppel M; Sarić T; Wernig M; Jänisch R; Brockmeier K; Hescheler J; Pillekamp F
FASEB J; 2010 Aug; 24(8):2739-51. PubMed ID: 20371616
[TBL] [Abstract][Full Text] [Related]
14. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Odontoblast-Like Cells From Mouse Induced Pluripotent Stem Cells by Pax9 and Bmp4 Transfection.
Seki D; Takeshita N; Oyanagi T; Sasaki S; Takano I; Hasegawa M; Takano-Yamamoto T
Stem Cells Transl Med; 2015 Sep; 4(9):993-7. PubMed ID: 26136503
[TBL] [Abstract][Full Text] [Related]
16. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
Li Y; Geng YJ
Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction.
Mauritz C; Martens A; Rojas SV; Schnick T; Rathert C; Schecker N; Menke S; Glage S; Zweigerdt R; Haverich A; Martin U; Kutschka I
Eur Heart J; 2011 Nov; 32(21):2634-41. PubMed ID: 21596799
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
19. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
[TBL] [Abstract][Full Text] [Related]
20. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
